Velan Capital Investment Management Lp Top Holdings and 13F Report (2025) About Velan Capital Investment Management LpInvestment ActivityVelan Capital Investment Management Lp has $101.24 million in total holdings as of June 30, 2025.Velan Capital Investment Management Lp owns shares of 50 different stocks, but just 14 companies or ETFs make up 80% of its holdings.Approximately 21.69% of the portfolio was purchased this quarter.About 22.70% of the portfolio was sold this quarter.This quarter, Velan Capital Investment Management Lp has purchased 47 new stocks and bought additional shares in 16 stocks.Velan Capital Investment Management Lp sold shares of 5 stocks and completely divested from 7 stocks this quarter.Largest Holdings Heron Therapeutics $14,462,560Verona Pharma PLC American Depositary Share $8,985,100JASPERTHERAPEUTICSINC $7,957,745Protara Therapeutics $6,481,170Zevra Therapeutics $6,299,150 Largest New Holdings this Quarter 171757206 - CIDARATHERAPEUTICSINC $4,871,000 Holding022307102 - ALUMISINC $4,862,538 Holding04335A105 - Arvinas $3,680,000 Holding640268906 - NEKTARTHERAPEUTICS $1,292,000 Holding92790C104 - Viridian Therapeutics $1,209,270 Holding Largest Purchases this Quarter CIDARATHERAPEUTICSINC 100,000 shares (about $4.87M)ALUMISINC 1,620,846 shares (about $4.86M)Arvinas 500,000 shares (about $3.68M)Rezolute 350,000 shares (about $1.56M)Sutro Biopharma 2,030,000 shares (about $1.45M) Largest Sales this Quarter PRAXISPRECISIONMEDICINESI 35,666 shares (about $1.50M)TOURMALINEBIOINC 61,523 shares (about $983.75K)Geron 585,000 shares (about $824.85K)Liquidia Technologies 60,740 shares (about $756.82K)Aclaris Therapeutics 2,300 shares (about $3.27K) Sector Allocation Over TimeMap of 500 Largest Holdings ofVelan Capital Investment Management Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorHRTXHeron Therapeutics$14,462,5600.0%6,986,74414.3%MedicalVRNAVerona Pharma PLC American Depositary Share$8,985,1000.0%95,0008.9%MedicalJASPERTHERAPEUTICSINC$7,957,7450.0%1,433,8287.9%COMNEWTARAProtara Therapeutics$6,481,170$1,427,736 ▲28.3%2,139,0006.4%MedicalZVRAZevra Therapeutics$6,299,150$440,500 ▲7.5%715,0006.2%MedicalTOURMALINEBIOINC$6,298,285$983,753 ▼-13.5%393,8896.2%COMPRAXISPRECISIONMEDICINESI$6,279,495$1,499,755 ▼-19.3%149,3346.2%COMNEWCIDARATHERAPEUTICSINC$4,871,000$4,871,000 ▲New Holding100,0004.8%COMNEWALUMISINC$4,862,538$4,862,538 ▲New Holding1,620,8464.8%COMARVNArvinas$3,680,000$3,680,000 ▲New Holding500,0003.6%MedicalSCPHscPharmaceuticals$3,496,3150.0%917,6683.5%MedicalRZLTRezolute$3,345,000$1,561,000 ▲87.5%750,0003.3%MedicalLQDALiquidia Technologies$2,981,180$756,821 ▼-20.2%239,2602.9%MedicalMLYSMineralys Therapeutics$2,362,338$324,720 ▲15.9%174,6002.3%MedicalSTROSutro Biopharma$2,184,534$1,449,217 ▲197.1%3,060,0002.2%MedicalNSPRInspireMD$2,052,1460.0%904,0292.0%MedicalPERSPECTIVETHERAPEUTICSINC$1,720,0000.0%500,0001.7%COMNEWREPLReplimune Group$1,700,841$9,290 ▲0.5%183,0831.7%MedicalTELATELA Bio$1,449,9750.0%747,4101.4%MedicalEDESABIOTECHINC$1,395,6250.0%687,5001.4%COMNEWNEKTARTHERAPEUTICS$1,292,000$1,292,000 ▲New Holding50,0001.3%CALLVRDNViridian Therapeutics$1,209,270$1,209,270 ▲New Holding86,5001.2%MedicalUPSTREAMBIOINC$1,174,8600.0%107,0001.2%COMELDNEledon Pharmaceuticals$918,617$40,650 ▲4.6%338,9730.9%MedicalAVALOTHERAPEUTICSINC$773,310$214,570 ▲38.4%154,9720.8%COMNEWTENAXTHERAPEUTICSINC$479,9980.0%83,3330.5%COMNEWCRBPCorbus Pharmaceuticals$407,1000.0%59,0000.4%MedicalKIORAPHARMACEUTICALSINC$352,0020.0%122,2230.3%COMPTGXProtagonist Therapeutics$204,499$204,499 ▲New Holding3,7000.2%MedicalCTMXCytomX Therapeutics$170,2500.0%75,0000.2%MedicalNRIXNurix Therapeutics$113,900$113,900 ▲New Holding10,0000.1%MedicalGERNGeron$98,700$824,850 ▼-89.3%70,0000.1%MedicalWVEWAVE Life Sciences$97,500$13,000 ▲15.4%15,0000.1%MedicalLRMRLarimar Therapeutics$95,370$14,450 ▲17.9%33,0000.1%MedicalGOSSGossamer Bio$92,2500.0%75,0000.1%MedicalPRQRProQR Therapeutics$91,8000.0%45,0000.1%MedicalVTYXVentyx Biosciences$85,6000.0%40,0000.1%MedicalERASErasca$82,550$19,050 ▲30.0%65,0000.1%MedicalALECAlector$77,0000.0%55,0000.1%MedicalTERNTerns Pharmaceuticals$74,600$11,190 ▲17.6%20,0000.1%MedicalDSGNDesign Therapeutics$67,400$20,220 ▲42.9%20,0000.1%MedicalCNTXContext Therapeutics$65,520$6,552 ▲11.1%100,0000.1%MedicalOVIDOvid Therapeutics$52,784$20,784 ▲64.9%160,0000.1%MedicalIMMXImmix Biopharma$51,750$51,750 ▲New Holding25,0000.1%MedicalVYNEVYNE Therapeutics$49,500$49,500 ▲New Holding30,0000.0%MedicalACRSAclaris Therapeutics$46,434$3,266 ▼-6.6%32,7000.0%MedicalFDMT4D Molecular Therapeutics$44,5200.0%12,0000.0%MedicalPYXSPyxis Oncology$44,000$44,000 ▲New Holding40,0000.0%MedicalPMVPPMV Pharmaceuticals$37,1000.0%35,0000.0%MedicalNXTCNextCure$20,700$9,200 ▲80.0%45,0000.0%MedicalSLRNAcelyrin$0$8,316,354 ▼-100.0%00.0%MedicalSWTXSpringWorks Therapeutics$0$8,186,998 ▼-100.0%00.0%MedicalINSTIL BIO INC$0$1,197,840 ▼-100.0%00.0%COM NEWIMNMImmunome$0$1,033,055 ▼-100.0%00.0%MedicalRGLSRegulus Therapeutics$0$140,000 ▼-100.0%00.0%MedicalKRONKronos Bio$0$28,875 ▼-100.0%00.0%MedicalELEVElevation Oncology$0$11,660 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access